Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study

OBJECTIVE: To evaluate the impact of adalimumab on health-related quality of life (HRQOL) for patients with moderate to severe plaque psoriasis. BACKGROUND: Psoriasis is a chronic, inflammatory, immune-mediated disease that has a significant impact on patients' HRQOL. Adalimumab is a fully huma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Revicki, Dennis A, Menter, Alan, Feldman, Steven, Kimel, Miriam, Harnam, Neesha, Willian, Mary K
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2008
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2579425/
https://ncbi.nlm.nih.gov/pubmed/18831744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7525-6-75
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados